NICE rejects Sativex in draft guidance on cannabis-based medicinal products
Draft guidance published today (August 8) does not recommend Sativex as a treatment for MS spasticity because it is not a cost effective treatment.
In November 2018, the legal status of cannabis was amended to allow specialist clinicians to legally prescribe cannabis-derived medicinal products to patients with an exceptional clinical need.
To support this change, NICE (National Institute for Health and Care Excellence) has reviewed evidence for the benefits and costs of cannabis-based medicinal products and drawn up guidance for health professionals and the public.
The draft guideline acknowledges that, for people with MS, Sativex can be an effective treatment for MS spasticity which has not responded to other therapies. However, Sativex is not recommended because, at its current list price, it is not considered to be cost-effective. The calculations used to reach this decision indicated that Sativex would be cost effective if the list price was reduced from £375 to £188 per pack.
The draft NICE guideline also does not recommend the use of cannabis-based medicinal products for people with chronic pain, including people with MS experiencing nerve pain.
The MS Trust is hugely disappointed that, once again, Sativex has been turned down because it is too expensive for the NHS.
- Paru Naik, Health Professional Programme Director, MS Trust
The MS Trust is reviewing the draft guideline from NICE and we will respond to the consultation process.
We encourage people to add their own comments on this draft guideline; you can do so via the NICE website by 5pm on 5 September 2019. The final guideline is expected to be published in November 2019.
"Starting a podcast in lockdown helped us take ownership of the situation"
23 Apr 2021 - 00:00
Comedian, Jeanette and Poet, Lytisha, talk about how creating their own podcast, about life with MS, led to lots of laughs, feelings of empowerment and a sense of community during lockdown.
Twelve year old Lacey hasn't been able to hug her dad for a year
23 Apr 2021 - 00:00
Before lockdown Lacey visited her dad every other weekend, but Covid restrictions have meant she’s not been able to visit her dad in his care home and give him a hug since March 2020.
'This is my normal now. I rather like it.' Living with PPMS in lockdown
23 Apr 2021 - 00:00
John Peters tells us how his working life changed during lockdown and how he’ll be quite happy not to go back to ‘normal’.
Sign up to our emails
Get the latest news and research sent straight to your inbox. Find out first about the latest developments in MS treatments, plus updates on the work of the MS Trust.
Share
